JP2005528413A5 - - Google Patents

Download PDF

Info

Publication number
JP2005528413A5
JP2005528413A5 JP2004500861A JP2004500861A JP2005528413A5 JP 2005528413 A5 JP2005528413 A5 JP 2005528413A5 JP 2004500861 A JP2004500861 A JP 2004500861A JP 2004500861 A JP2004500861 A JP 2004500861A JP 2005528413 A5 JP2005528413 A5 JP 2005528413A5
Authority
JP
Japan
Prior art keywords
acrylate
transdermal
naphthol
tetrahydro
thienyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004500861A
Other languages
English (en)
Japanese (ja)
Other versions
JP5253707B2 (ja
JP2005528413A (ja
Filing date
Publication date
Priority claimed from DE10220230A external-priority patent/DE10220230A1/de
Application filed filed Critical
Publication of JP2005528413A publication Critical patent/JP2005528413A/ja
Publication of JP2005528413A5 publication Critical patent/JP2005528413A5/ja
Application granted granted Critical
Publication of JP5253707B2 publication Critical patent/JP5253707B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2004500861A 2002-05-06 2003-05-05 レストレスレッグス症候群を処置するための経外角皮的投与形 Expired - Lifetime JP5253707B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10220230A DE10220230A1 (de) 2002-05-06 2002-05-06 Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms
DE10220230.3 2002-05-06
PCT/EP2003/004685 WO2003092677A1 (de) 2002-05-06 2003-05-05 Transepikutane darreichungsform zur behandlung des restless leg syndroms

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010098924A Division JP2010159302A (ja) 2002-05-06 2010-04-22 レストレスレッグス症候群を処置するための経外角皮的投与形

Publications (3)

Publication Number Publication Date
JP2005528413A JP2005528413A (ja) 2005-09-22
JP2005528413A5 true JP2005528413A5 (https=) 2006-02-16
JP5253707B2 JP5253707B2 (ja) 2013-07-31

Family

ID=29285132

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004500861A Expired - Lifetime JP5253707B2 (ja) 2002-05-06 2003-05-05 レストレスレッグス症候群を処置するための経外角皮的投与形
JP2010098924A Pending JP2010159302A (ja) 2002-05-06 2010-04-22 レストレスレッグス症候群を処置するための経外角皮的投与形

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010098924A Pending JP2010159302A (ja) 2002-05-06 2010-04-22 レストレスレッグス症候群を処置するための経外角皮的投与形

Country Status (23)

Country Link
EP (1) EP1501499B1 (https=)
JP (2) JP5253707B2 (https=)
KR (1) KR20040104697A (https=)
CN (1) CN100396281C (https=)
AT (1) ATE387912T1 (https=)
AU (1) AU2003233233B2 (https=)
BR (1) BR0309837A (https=)
CA (2) CA2787384A1 (https=)
CY (1) CY1107452T1 (https=)
DE (2) DE10220230A1 (https=)
DK (1) DK1501499T3 (https=)
ES (1) ES2301795T3 (https=)
IL (2) IL164861A0 (https=)
MX (1) MXPA04010687A (https=)
NO (1) NO333619B1 (https=)
NZ (1) NZ536533A (https=)
PL (1) PL218549B1 (https=)
PT (1) PT1501499E (https=)
RU (1) RU2301063C9 (https=)
SI (1) SI1501499T1 (https=)
UA (1) UA81625C2 (https=)
WO (1) WO2003092677A1 (https=)
ZA (1) ZA200408862B (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10041478A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
DE10359528A1 (de) 2003-12-18 2005-07-28 Schwarz Pharma Ag (S)-2-N-Propylamino-5-hydroxytetralin als D3-agonistisches Therapeutikum
BRPI0621655A2 (pt) * 2006-05-08 2011-12-20 Teikoku Seiyaku Kk preparação para a absorção percutánea de uma droga antidemência básica
TWI392670B (zh) * 2006-06-22 2013-04-11 Ucb Pharma Gmbh 經取代的２-胺基萘滿之於製造用於預防、減緩及／或治療各種類型疼痛之藥物上的用途
EP1987815A1 (en) * 2007-05-04 2008-11-05 Schwarz Pharma Ag Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders
SI2215072T1 (sl) 2007-11-28 2015-10-30 Ucb Pharma Gmbh Polimorfna oblika rotigotina
EP2258369B1 (en) * 2008-02-27 2015-04-08 Hisamitsu Pharmaceutical Co., Inc. Medicated patch
JP5546013B2 (ja) 2008-02-27 2014-07-09 久光製薬株式会社 貼付剤及び包装体
EP2201941A1 (de) 2008-12-29 2010-06-30 UCB Pharma GmbH Pflaster-Herstellungstechnologie
EP2281559A1 (en) 2009-06-26 2011-02-09 UCB Pharma GmbH Pharmaceutical composition comprising rotigotine salts (acid or Na), especially for iontophoresis
US9925150B2 (en) * 2009-12-22 2018-03-27 Lts Lohmann Therapie-Systeme Ag Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine
US8729306B2 (en) 2010-02-05 2014-05-20 Ucb Pharma Gmbh Process for the preparation of nitrogen substituted aminotetralins derivatives
AU2011268871C1 (en) 2010-06-25 2015-06-04 Ucb Pharma Gmbh Processes for the resolution of nitrogen substituted (S) - 5 -alkoxy- 2 -aminotetralin derivatives
EP2559435A1 (en) 2011-08-19 2013-02-20 UCB Pharma GmbH Rotigotine in the treatment of hemispatial neglect, stroke and deficits following stroke
DE102012013439A1 (de) 2012-07-03 2014-01-23 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System umfassend Rotigotin und Kristallisationsinhibitor
DE102012013421A1 (de) 2012-07-03 2014-01-09 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System (TTS) mit Rotigotin
WO2013075822A1 (en) 2011-11-22 2013-05-30 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermal therapeutic system (tts) with rotigotine
KR101558042B1 (ko) * 2012-07-05 2015-10-07 에스케이케미칼주식회사 로티고틴을 함유한 경피흡수제제
KR101558043B1 (ko) * 2012-07-06 2015-10-07 에스케이케미칼주식회사 로티고틴 함유 경피흡수제제
TW201431570A (zh) 2012-11-22 2014-08-16 Ucb Pharma Gmbh 用於經皮投服羅替戈汀（Ｒｏｔｉｇｏｔｉｎｅ）之多天式貼片
EP3016641B1 (de) 2013-07-03 2018-09-05 LTS Lohmann Therapie-Systeme AG Transdermales therapeutisches system mit elektronischem bauteil
JPWO2015129527A1 (ja) 2014-02-27 2017-03-30 株式会社 メドレックス プラミペキソールを含有する神経変性疾患の治療用貼付剤
US11752110B2 (en) 2014-05-20 2023-09-12 Lts Lohmann Therapie-Systeme Ag Transdermal delivery system including an interface mediator
EP3145502B1 (en) 2014-05-20 2022-07-06 LTS Lohmann Therapie-Systeme AG Transdermal delivery system containing rotigotine
WO2015177209A1 (en) 2014-05-20 2015-11-26 Lts Lohmann Therapie-Systeme Ag Method for adjusting the release of active agent in a transdermal delivery system
CN113950356B (zh) 2019-06-14 2024-12-31 久光制药株式会社 含罗替戈汀的贴附剂
DK3854388T3 (da) 2020-01-24 2023-11-27 Luye Pharma Switzerland Ag Transdermalt terapeutisk system omfattende rotigotin og mindst et ikke-aminresistent silikoneklæbestof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5232702A (en) * 1991-07-22 1993-08-03 Dow Corning Corporation Silicone pressure sensitive adhesive compositons for transdermal drug delivery devices and related medical devices
DE4238223C1 (de) * 1992-11-12 1994-05-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Verabreichung von Physostigmin an die Haut und Verfahren zu dessen Herstellung
US5482988A (en) * 1994-01-14 1996-01-09 Dow Corning Corporation Hot-melt silicone pressure sensitive adhesive with siloxylated polyether waxes as additives
IL116539A (en) * 1995-01-06 2002-02-10 Noven Pharma Preparations given through the skin of unstable anti-acid drugs
FR2749514B1 (fr) * 1996-06-11 1998-08-07 Hoechst Marion Roussel Systemes transdermiques renfermant 2 principes actifs dans des compartiments separes, leur procede de preparation et leur application comme medicament
DE19701619B4 (de) * 1997-01-17 2007-10-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Pramipexol zur Behandlung des restless legs syndroms
DE19814084B4 (de) * 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
DE19938825A1 (de) * 1999-08-19 2001-04-26 Boehringer Ingelheim Pharma Wirkstoffkombination mit Clonidin
DE19938823A1 (de) * 1999-08-19 2001-02-22 Boehringer Ingelheim Pharma Medikamentöse Behandlung des Restless Leg Syndroms
DE10041479A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
EP1256340B1 (en) * 2001-05-08 2003-08-13 Schwarz Pharma Ag Improved transdermal therapeutic system for the treatment of Parkinson's disease
PT1256339E (pt) * 2001-05-08 2004-02-27 Lohmann Therapie Syst Lts Sistema terapeutico transdermico para doenca de parkinson que induz niveis plasmaticos altos de rotigotina

Similar Documents

Publication Publication Date Title
JP2005528413A5 (https=)
JP5253707B2 (ja) レストレスレッグス症候群を処置するための経外角皮的投与形
US9265752B2 (en) Transdermal patch containing Rotigotine
JP5542665B2 (ja) マトリックス型経皮投与剤およびその製造方法
US20040048779A1 (en) Use of rotigotine for treating the restless leg syndrome
JP2013056944A (ja) メチルフェニデートで注意欠乏障害及び注意欠乏／活動亢進障害を治療する組成物及び方法
JP2006528144A (ja) プラミペキソール活性剤を含む経皮治療システム
JP2017519837A (ja) 経皮送達システム
JP3159688B2 (ja) 経皮吸収テープ剤
WO2000019986A1 (en) Tape material for transcutaneous absorption
CN104797245B (zh) 丙炔基氨基茚满透皮组合物
US20170071880A1 (en) Selegiline transdermal system
JP7716111B2 (ja) 神経変性疾患の症状の緩和又は治療のための貼付剤
CN102970974A (zh) 用于治疗皮炎和牛皮癣的去炎松缩酮制剂
HK1072541B (en) Trans-epicutaneous administration form for treating restless leg syndrome
HK1142805A (en) Composition comprising rotigotine, its use and transdermal patch comprising the composition
HK1207558B (zh) 丙炔基氨基茚满透皮组合物
HK1142805B (en) Composition comprising rotigotine, its use and transdermal patch comprising the composition
HK1031196B (en) Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof